Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Oral Oncol. 2022 Mar 23;128:105806. doi: 10.1016/j.oraloncology.2022.105806

Figure 2.

Figure 2.

Reduction in phospho-eIF4E staining by immunohistochemistry in Patient 2. (A) Pretreatment biopsy specimen showing characteristics of nonkeratinizing squamous cell carcinoma. (B) Pretreatment biopsy specimen stained with phospho-eIF4E. (C) Posttreatment biopsy specimen stained with phospho-eIF4E.